Barrett Elizabeth 4
4 · Sage Therapeutics, Inc. · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Barrett Elizabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-10+12,500→ 12,500 totalExercise: $10.90Exp: 2034-06-09→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 10, 2025 or the day immediately prior to the 2025 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.